| Literature DB >> 26546282 |
Tineke Cantaert1, Jean-Nicolas Schickel1, Jason M Bannock1, Yen-Shing Ng1, Christopher Massad1, Tyler Oe1, Renee Wu1, Aubert Lavoie2, Jolan E Walter3, Luigi D Notarangelo4, Waleed Al-Herz5, Sara Sebnem Kilic6, Hans D Ochs7, Shigeaki Nonoyama8, Anne Durandy9, Eric Meffre10.
Abstract
Activation-induced cytidine deaminase (AID), the enzyme-mediating class-switch recombination (CSR) and somatic hypermutation (SHM) of immunoglobulin genes, is essential for the removal of developing autoreactive B cells. How AID mediates central B cell tolerance remains unknown. We report that AID enzymes were produced in a discrete population of immature B cells that expressed recombination-activating gene 2 (RAG2), suggesting that they undergo secondary recombination to edit autoreactive antibodies. However, most AID+ immature B cells lacked anti-apoptotic MCL-1 and were deleted by apoptosis. AID inhibition using lentiviral-encoded short hairpin (sh)RNA in B cells developing in humanized mice resulted in a failure to remove autoreactive clones. Hence, B cell intrinsic AID expression mediates central B cell tolerance potentially through its RAG-coupled genotoxic activity in self-reactive immature B cells.Entities:
Keywords: AID-deficient patients; B cell development; B cell tolerance; activation-induced cytidine deaminase
Mesh:
Substances:
Year: 2015 PMID: 26546282 PMCID: PMC4654975 DOI: 10.1016/j.immuni.2015.10.002
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 31.745